Pharmacovigilance Risk Assessment Committee (PRAC) criteria to prioritise impact research (Rev.1)
Veterinary medicines European public assessment report (EPAR): Dexdomitor, dexmedetomidine, Status: Authorised
Recommended submission dates for veterinary medicinal products
Agenda - Information session on the pilot for expert panels' advice for orphan medical devices
Lidocaine (bovine): European Public MRL Assessment Report (EPMAR) - CVMP
Lidocaine (porcine species): European Public MRL Assessment Report (EPMAR) - CVMP
Decision of the Executive Director on transparency measures for senior staff leaving the Agency
Joint Committee Opinion 27/2020 on criteria and restrictions for senior staff applying for occupational activities within two years after leaving the Agency
Establishing efficacy based on single-arm trials submitted as pivotal evidence in a marketing authorisation
Reflection paper on establishing efficacy based on single-arm trials submitted as pivotal evidence in a marketing authorisation application